You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金河生物(002688.SZ)擬將2019年度審計機構由瑞華變更為信永中和
格隆匯 12-06 20:44

格隆匯12月6日丨金河生物(002688.SZ)公佈,公司於2019年12月6日召開了第四屆董事會第三十次會議,審議通過了《關於變更會計師事務所的議案》,擬將公司2019年度審計機構由瑞華會計師事務所(特殊普通合夥)(“瑞華會計師事務所”)變更為信永中和會計師事務所(特殊普通合夥)(“信永中和會計師事務所”)。

公司原審計機構為瑞華會計師事務所,根據客觀情況及公司經營發展及戰略需要,經審慎考慮,擬終止與瑞華會計師事務所的審計合作。由公司董事會審計委員會提議,經公司第四屆董事會第三十次會議和第四屆監事會第十九次會議審議通過,公司擬聘任具備證券、期貨業務資格的信永中和會計師事務所為公司2019年度審計機構,聘期一年。本議案尚須公司股東大會審議,並提請股東大會授權公司董事會根據行業標準及公司審計的實際工作情況,與信永中和會計師事務所協商確定審計費用。

公司已就更換會計師事務所事項與瑞華會計師事務所進行了溝通,公司對瑞華會計師事務所多年來為公司提供的專業審計服務工作表示誠摯的感謝。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account